Search Results - "Gareau, Alison J."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection by Krummey, Scott M, Gareau, Alison J

    Published in Frontiers in immunology (05-08-2022)
    “…Advances in hematopoietic stem cell transplant (HSCT) have led to changes in the approach to donor selection. Many of these new approaches result in greater…”
    Get full text
    Journal Article
  2. 2
  3. 3

    HLA Genotype Imputation Results in Largely Accurate Epitope Mismatch Risk Categorization Across Racial Groups by Cohen, Gregory S, Gareau, Alison J, Kallarakal, Melissa A, Farooq, Tayyiaba, Bettinotti, Maria P, Sullivan, H Cliff, Madbouly, Abeer, Krummey, Scott M

    Published in Transplantation direct (01-07-2024)
    “…Biomarkers that predict posttransplant alloimmunity could lead to improved long-term graft survival. Evaluation of the number of mismatched epitopes between…”
    Get full text
    Journal Article
  4. 4

    Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer by Gareau, Alison J., Brien, Colin, Gebremeskel, Simon, Liwski, Robert S., Johnston, Brent, Bezuhly, Michael

    Published in Clinical & experimental metastasis (01-02-2018)
    “…Activated platelets promote the proliferation and metastatic potential of cancer cells. Platelet activation is largely mediated through ADP engagement of…”
    Get full text
    Journal Article
  5. 5

    Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy by Gareau, Alison J., MSc, Nashan, Bjorn, MD, PhD, Hirsch, Gregory M., MD, Lee, Timothy D.G., PhD

    “…Background Late cardiac graft rejection, primarily mediated by allograft vasculopathy (AV), remains a major limitation to cardiac transplantation, even in the…”
    Get full text
    Journal Article
  6. 6

    Next‐generation sequencing identifies two novel HLA class II alleles, HLA‐DRB101:115 and HLA‐DRB114:224 by Abu‐Khader, Ahmad, Gareau, Alison J., Burns, Caitlyn, Khan, Faisal, Berka, Noureddine

    Published in HLA : immune response genetics (01-08-2022)
    “…We identified two novel HLA class II alleles by NGS, HLA‐DRB1*01:115 and HLA‐DRB1*14:224…”
    Get full text
    Journal Article
  7. 7

    Promotion of Primary Murine Breast Cancer Growth and Metastasis by Adipose-Derived Stem Cells Is Reduced in the Presence of Autologous Fat Graft by Gebremeskel, Simon, Gencarelli, John, Gareau, Alison J., Levatte, Terry, Dugandzic, B.Sc, Anton, Johnston, Brent, Bezuhly, Michael

    Published in Plastic and reconstructive surgery (1963) (01-01-2019)
    “…Cell-assisted lipotransfer involves enrichment of autologous fat with supraphysiologic numbers of adipose-derived stem cells to improve graft take…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The identification of a novel HLA‐B allele, HLA‐B27:05:38 by Gareau, Alison J., Mostafa, Ahmed A., Stamm, Luz, Khan, Faisal, Berka, Noureddine

    Published in HLA (01-08-2019)
    “…HLA‐B*27:05:38 differs from HLA‐B*27:05:02:01 by 2 mismatches in exon 3, resulting in 2 synonymous mutations…”
    Get full text
    Journal Article
  10. 10

    Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease by Chisholm, Jessica, Gareau, Alison J., Byun, Stephanie, Paletz, Justin L., Tang, David, Williams, Jason, LeVatte, Terry, Bezuhly, Michael

    Published in Plastic and reconstructive surgery (1963) (01-11-2017)
    “…Although surgical excision and intralesional collagenase injection are mainstays in Dupuytren disease treatment, no effective medical therapy exists for…”
    Get full text
    Journal Article
  11. 11

    Identification of a novel HLA‐C allele, HLA‐C07:778, in an unrelated hematopoietic stem cell donor by Gareau, Alison J., Mostafa, Ahmed A., Williams, Jolene, Stamm, Luz, Berka, Noureddine

    Published in HLA (01-08-2019)
    “…HLA‐C*07:778 differs from HLA‐C*07:01:01:01 by a single nonsynonymous nucleotide substitution at codon 263 (CAC→CAG)…”
    Get full text
    Journal Article
  12. 12

    Pre-transplant AT1R antibodies correlate with early allograft rejection by Gareau, Alison J., Wiebe, Chris, Pochinco, Denise, Gibson, Ian W., Ho, Julie, Rush, David N., Nickerson, Peter W.

    Published in Transplant immunology (01-02-2018)
    “…Studies investigating the potential pathogenic effects of non-HLA antibodies (Ab) have identified Ab against the angiotensin II type 1 receptor (AT1R-Ab) as a…”
    Get full text
    Journal Article
  13. 13

    Pre-transplant AT 1 R antibodies correlate with early allograft rejection by Gareau, Alison J, Wiebe, Chris, Pochinco, Denise, Gibson, Ian W, Ho, Julie, Rush, David N, Nickerson, Peter W

    Published in Transplant immunology (01-02-2018)
    “…Studies investigating the potential pathogenic effects of non-HLA antibodies (Ab) have identified Ab against the angiotensin II type 1 receptor (AT R-Ab) as a…”
    Get full text
    Journal Article
  14. 14

    Antibody therapy can enhance AngiotensinII-induced myocardial fibrosis by Rosin, Nicole L, Gareau, Alison J, Betsch, Devin, Falkenham, Alec, Sopel, Mryanda J, Lee, Timothy Dg, Légaré, Jean-Francois

    Published in Fibrogenesis & tissue repair (10-04-2014)
    “…Myocardial fibrosis is a pathological process that is characterized by disrupted regulation of extracellular matrix proteins resulting in permanent scarring of…”
    Get full text
    Journal Article
  15. 15
  16. 16